N. Hindi, F. Duffaud, G. G. Baldi, and P. Pautier, “Use of first-line trabectedin in advanced leiomyosarcoma: a review of clinical data and future perspectives:  ”, CBN, vol. 4, no. 1, pp. 6–10, Mar. 2016.